Stay updated on Switch to Dolutegravir + Rilpivirine Clinical Trial
Sign up to get notified when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.

Latest updates to the Switch to Dolutegravir + Rilpivirine Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page’s revision tag was updated from v3.6.5 to v3.6.6, signaling a new release/patch rather than a content alteration. This appears to be a backend/format update rather than a change to study data or visible content.SummaryDifference0.0%

- Check20 days agoChange DetectedA new line '2014 ( U.S. NIH Grant/Contract )' was added to the study's identifiers. This reflects the NIH funding source for the trial.SummaryDifference0.0%

- Check34 days agoChange DetectedIPD sharing information and related metadata were added to the study page, including IPD access details and plan descriptions, along with updated revision metadata.SummaryDifference100%

- Check41 days agoChange DetectedIPD sharing information, study documents, and related metadata were removed from the Study Details page, reducing public access to data-sharing details and essential documentation.SummaryDifference19%

- Check55 days agoChange DetectedThe page revision has been updated from v3.6.3 to v3.6.4, indicating a new version of the page. This update appears to involve minor deployment changes without altering the study content or displayed information.SummaryDifference0.0%

- Check77 days agoChange DetectedUpdated the page revision from v3.6.0 to v3.6.3 on the Study Details page, reflecting a newer revision tag for the entry. The modification concerns metadata about the page update and does not change the study data or descriptions.SummaryDifference0.0%

Stay in the know with updates to Switch to Dolutegravir + Rilpivirine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.